INTRODUCTION
Giant cell lesion (GCL) of the jaws is a nonneoplastic proliferative process, divided into central giant cell lesion (CGCL) and peripheral giant cell lesion (PGCL). PGCL is considered a reactive process induced by local irritants on the gingiva or alveolar mucosa. CGCL is an intra-osseous lesion of unknown etiology 11 . Both CGCL and PGCL exhibit similar histopathological features, and are characterized by the presence of abundant mononuclear stromal cells, admixed with a large number of multinucleated giant cells and a rich vascularized stroma with extravasated erythrocytes, hemosiderin deposition, and blood-¿OOHG SRROV In spite of this, these lesions may have different clinical behaviors 11, 13, 23 . Fatty acid synthase (FASN) is the metabolic enzyme responsible for endogenous synthesis of saturated long-chain fatty acid, specifically palmitate, from the precursors acetyl-CoA and malonyl-CoA 7 . FASN is overexpressed in a variety of human cancers affecting breast 19 , ovaries 2 , prostate 20 , and oral cavity 22 , whereas FASN is downregulated in most normal human tissues (except in the liver, lactating breast, fetal lung, and adipose tissue) because cells preferentially use circulating dietary fatty acids for the synthesis of new structural lipids 29 . In the oral cavity, FASN expression has been shown in squamous cell carcinoma and melanoma 3, 22 ; however, its expression in benign neoplasms 3 and/or reactive conditions is little known. Interestingly, some studies have linked FASN expression with endothelial cell proliferation 4, 21 . Accordingly, the role of FASN expression in angiogenesis must be EHWWHU GH¿QHG 7R RXU NQRZOHGJH )$61 UHDFWLYLW\ in GCL of the jaws is unknown.
CD34 is a cell surface glycoprotein consistently expressed in the vascular endothelium. Some studies have previously assessed CD34 expression in CGCL in order to compare aggressive and non-aggressive subtypes. They showed increased microvessel density (MVD)-CD34 in aggressive CGCL 10,18,25 . Although CD34 is unable to distinguish between pre-existing vessels and neoformed vessels, interestingly, it has been shown that distinguishing neoformed vessels in proliferative tissues is relevant and may have prognostic implications, identifying possible targets for developing anti-angiogenic therapeutic strategies 5, 18 . CD105 (endoglin) is an angiogenic membrane protein that is highly expressed in neoformed vessels 6 . Although CD105 has been assessed in oral vascular malformations and pyogenic granulomas 26 , to our knowledge, CD105 expression in GCL of the jaws is unknown. Another unclear and relevant point is the characterization of the lymphatic MVD (LMVD) in GCL, which may be immunohistochemically evaluated through the D2-40 marker 13 . Nevertheless, as in the case of CD105, the lymphatic vascular stroma characterization in GCL of the jaws has not been evaluated.
As previously mentioned, increased FASN expression in oral malignant tumors has been reported 3, 22 , and some studies have linked FASN expression with endothelial cell proliferation 4, 21 . It remains to be determined what happens with such events in oral benign and/or reactive lesions. Thus, the aim of the current study was to assess angiogenesis and lymphangiogenesis, as well as establishing their relationship with FASN expression in CGCL and PGCL of the jaws. 
MATERIAL AND METHODS

Immunohistochemical methods
For each antibody (FASN, CD34, CD105 and D2-ǋPWKLFN VHFWLRQV PRXQWHG RQ VLODQHFRDWHG glass slides were used. All tissue specimens were ¿[HG LQ QHXWUDOEXIIHUHG IRUPDOLQ IRU KRXUV DW URRP WHPSHUDWXUH HPEHGGHG LQ SDUDI¿Q DW & and cut into parallel consecutive sections. For the immunohistochemical (IHC) reactions, the slides were hydrated and treated with hydrogen peroxide (3%). Primary antibodies, dilutions and antigen retrieval are shown in Table 1 . The tissue sections were then washed three times in phosphate buffered saline (PBS) solution and exposed to secondary antibody using the LSAB+Kit (Dako, Carpinteria, CA, USA). Peroxidase activity was visualized by using the chromogen diaminobenzidine (DAB) 
)$61 H[SUHVVLRQ DQJLRJHQHVLV DQG O\PSKDQJLRJHQHVLV LQ FHQWUDO DQG SHULSKHUDO JLDQW FHOO OHVLRQV
I m m u n o s t a i n i n g a s s e s s m e n t a n d statistical analysis
MVD and microvessel area (MVA), assessed through CD34 and CD105 expression, as well as lymphatic MVD (LMVD) and MVA (LMVA), assessed through D2-40 expression, were established identifying the most vascularized areas within the lesions ("hot spots"), which were chosen at low magnification (100x) and subsequently SKRWRJUDSKHG LQ ¿YH KLJKSRZHU ¿HOGV DW [ PDJQL¿FDWLRQ 14 . The data collected were recorded and organized in a database using Statistical Package for Social Science (version 17.0; SPSS Inc., Chicago, IL, USA). Normal distribution was tested using the ShapiroWilk test. In samples with a normal distribution, the Student t-test and Pearson correlation were applied. In samples that presented non-normal distributions, the Mann-Whitney U test and Spearman correlation were applied. A P<0.05 probability value was FRQVLGHUHG VWDWLVWLFDOO\ VLJQL¿FDQW (Figures 1a, 1b; Figure 2a) . However, no statistical difference regarding the number of CD105-and D2-40-positive vessels was found when comparing both lesions (Figures 1c, 1d; Figure 2a; Figures 3a, 3b) . Table 2) .
RESULTS
All
Moreover, through consecutive section analysis, we found focal areas showing vessels stained with (Figures 3c, 3d) , supporting the idea that some CD105-stained vessels represent newly formed lymphatic vessels.
All cases present FASN-positive multinucleated giant cells (PGCL, mean 39%; CGCL, mean 36%) and mononuclear cells (PGCL, mean 7%; CGCL, mean 10%) (Figure 2c; Figures 4a, 4b) 
DISCUSSION
Both CGCL and PGCL of the jaws exhibit similar histopathological features, being characterized by numerous ovoid and spindle-shaped mononuclear cells, admixed with multinucleated giant cell, within a rich vascularized stroma 11, 16 . Despite this, it is well known that these lesions may have different clinical behaviors Angiogenesis, which is the formation of new vessels from pre-existing vessels, is thought to be of crucial importance to the growth and maintenance of proliferative tissues 24 . In the oral cavity, it has been shown that the number and size of blood vessels increase from normal oral epithelium through dysplastic epithelium to reach a maximum in invasive carcinoma 1 , while no significant difference seems to occur between normal mucosa, hyperplasia, and dysplasia for LMVD. Conversely, invasive carcinomas presented higher LMVD Regarding benign and reactive oral lesions, several studies have been performed to quantify MVD by using CD34 and CD105 9, 10, 12, 18, [25] [26] [27] , but none of them have assessed GCL considering both markers. In addition, although D2-40 expression has been demonstrated in normal odontogenic tissues as well as in cystic and tumor odontogenic lesions 30 , it is noteworthy that in GCL a stromal lymphatic vessel characterization has not been performed. Like CD105, D2-40 expression in GCL is unknown.
In the current study, we have observed uniform positivity for CD34 in all vascular structures in both lesions. Almost all our cases (93% and 92% of the PGCL and CGCL, respectively) exhibited CD105-positive vessels (about 32%, in relation to CD34-positive vessels), while only 78% and 69% of the PGCL and CGCL, respectively, showed D2-40-positive vessels (about 10%, in relation to CD34-positive vessels). Thus, the constitutive expression of CD105 in GCL supports angiogenic activity and tissue remodeling. This is further supported by FASN expression in endothelial cells, detected focally in about 46% and 21% of CGCL and PGCL cases, respectively. Moreover, the expression of endothelial markers in GCL is consistent with the presence of various angiogenic factors and matrix metalloproteinases (MMPs), such as tumor necrosis factor-alpha (TNF-α), transforming growth IDFWRUEHWD 7*)ǃ EDVLF¿EUREODVW JURZWK IDFWRU (b-FGF), vascular endothelial growth factor (VEGF), and MMP-9 15, 16, 28 . Since it has been shown that aggressive rather than nonaggressive subtypes of CGCL present higher MVD-CD34 10, 18, 25 , further studies are needed in order to compare whether there are CD105 expression differences between aggressive and nonaggressive subtypes of CGCL. In relation to stromal lymphatic vessel characterization, it is interesting that lymphangiogenesis in reactive or benign oral lesions have been little studied. In the current study, we have shown that about 8% and 13% of the vessels in CGCL and PGCL group, respectively, were immunoreactive for ' $OWKRXJK ZLWKRXW VWDWLVWLFDOO\ VLJQL¿FDQW GLIIHUHQFH EHWZHHQ 3*&/ DQG &*&/ S LW is suggested that the higher number of lymphatic vessels detected in PGCL (Figure 2) , which favored a reactive nature for PGCL. It is likely that, in addition to the anatomical location of these lesions, differences in the expression pattern of angiogenic growth factors 1, 16 may help to explain the differences found in our study. It has been shown that FASN inhibition by orlistat may reduce endothelial cell proliferation and angiogenesis 4 . As previously commented, to our knowledge, the FASN immunoexpression in giant cell lesions is unknown. However, in our study, different from 
CONCLUSION
In summary, our results suggest that greater MVD-CD34, and greater MVA-CD34, CD105 and D2-40, in PGCL rather than in CGCL, might be associated with a reactive inflammatory process. Moreover, similar levels of FASN expression, neoangiogenesis (MVD-CD105), and lymphangiogenesis (LMVD-D2-40) between PGCL and CGCL indicate constitutive processes to regulate tissue maintenance and remodeling in both lesions.
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